Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
05:05aSANOFI : Gets a Neutral rating from Berenberg
MD
05:01aROCHE HOLDINGS AG : Berenberg gives a Neutral rating
MD
05:01aNOVO NORDISK : Gets a Neutral rating from Berenberg
MD
05:01aGLAXOSMITHKLINE : Berenberg gives a Buy rating
MD
05:01aASTRAZENECA : Berenberg gives a Buy rating
MD
05:01aNOVARTIS AG : Gets a Buy rating from Berenberg
MD
04:26aSANOFI : Gets a Buy rating from JP Morgan
MD
04:24aASTRAZENECA : JP Morgan reaffirms its Buy rating
MD
02:00aRussian scientist behind COVID-19 vaccine defends 'wartime' roll-out
RE
09/28PFIZER : FDA Approves Xeljanz to Treat Active Polyarticular Course Juvenile Idiopathic Arthritis
DJ
09/28Bayer Says European Commission Authorizes XtendFlex Soybeans
DJ
09/28GLAXOSMITHKLINE : TREASURIES-Yields flat on quiet day ahead of presidential debate
RE
09/28ASTRAZENECA : Italian firm developing AstraZeneca's COVID-19 vaccine might go public - CEO
RE
09/28ABBOTT LABORATORIES : Glucose Monitor Gets European Approval
DJ
09/28ABBVIE : Gets Orphan Drug Designation for Spinal Cord Injury Treatment
DJ
Discover
09/28Merck KGaA Appoints New Executive Board Chair, CEO
DJ
09/28INOVIO PHARMACEUTICALS : potential COVID-19 vaccine trial on partial clinical hold
RE
09/28MERCK KGAA : DZ Bank reaffirms its Buy rating
MD
09/28RELIEF THERAPEUTICS : deal with biggest owner lifts cash to $52 mln for COVID-19 trials
RE
09/28RELIEF THERAPEUTICS : deal with biggest owner lifts cash to $52 mln for COVID-19 trials
RE
09/28MERCK KGAA : Goldman Sachs reaffirms its Sell rating
MD
09/28ROCHE : says 59% of SMA patients getting Evrysdi can sit - trial data
RE
09/28China Evergrande shares jump on debt reduction progress
RE
09/27China Evergrande New Energy Plans to Issue Up to 1.56 Billion A-Shares in Shanghai Listing
DJ
09/27GLAXOSMITHKLINE : First U.K. Patient Receives Trial Drug as Treatment for Covid-19
DJ
09/25JOHNSON & JOHNSON, NIKE, ILLUMINA : Stocks That Defined the Week
DJ
09/25GLAXOSMITHKLINE : Gets FDA Approval for Blood-Disorder Drug Nucala
DJ
09/25JOHNSON & JOHNSON : Covid-19 Vaccine Produced Immune Response in Earlier-Stage Study
DJ
09/25SARTORIUS VORZUEGE : Receives a Buy rating from JP Morgan
MD
09/25PHILIPS NV : JP Morgan reiterates its Neutral rating
MD
09/25MORPHOSYS : Goldman Sachs sticks Neutral
MD
09/25VERTEX PHARMACEUTICALS : Pharma Gets FDA Approval for New Ages for Cystic Fibrosis Treatment
DJ
09/25GERRESHEIMER AG : JP Morgan reiterates its Neutral rating
MD
09/25NOVO NORDISK : UBS reiterates its Neutral rating
MD
09/25DYNAVAX TECHNOLOGIES : China's Clover says its coronavirus vaccine candidate showed promise in animal test
RE
09/25SARTORIUS VORZUEGE : Gets a Neutral rating from Berenberg
MD
09/25China Evergrande shares, bonds suffer sell-off on cash-crunch concern
RE
09/25EXCLUSIVE : AstraZeneca gets partial immunity in low-cost EU vaccine deal
RE
09/25AstraZeneca gets partial immunity in low-cost EU vaccine deal
RE
09/24BAYER : resolves more Roundup cases, judge keeps pause on litigation
RE
09/24BAYER : resolves more Roundup cases, judge keeps pause on litigation
RE
09/24BECTON DICKINSON AND : in $60 Million Multistate Settlement on Pelvic Mesh Products
DJ
09/24Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial
RE
09/24BOSTON SCIENTIFIC : Pulmonx Corp. Sets IPO at 6.67 Million Shares; Sees Pricing at $14-$16 Each
DJ
09/24STRATEC BIOMEDICAL SYSTEMS AG : Buy rating from Berenberg
MD
09/24UK shares drop as job support scaled back; AstraZeneca weighs
RE
09/24ASTRAZENECA : still waiting for FDA go-ahead to resume U.S. trial
RE
09/24INDIVIOR : targets $70 million savings through job cuts, restructuring
RE
09/24EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source
RE
09/23Gilead to pay $97 million to settle U.S. kickback probe
RE
09/23Brazil's Sao Paulo likely to start COVID-19 immunization in December
RE
09/23AC IMMUNE : Down 43%; Semorinemab Didn't Meet Endpoint in Early Alzheimer's Disease
DJ
09/23EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source
RE
09/23EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source
RE
09/23ROCHE HOLDINGS AG : Goldman Sachs gives a Buy rating
MD
09/23Roche Alzheimer's drug fails, joining long list of trial flops
RE
09/23AC IMMUNE : Down; Semorinemab Didn't Meet Efficacy Endpoint in Early Alzheimer's Disease
DJ
09/23NOVARTIS AG : Sell rating from Barclays
MD
09/23BAXTER INTERNATIONAL : Gets FDA OK of Higher-Protein Clinimix, Clinimix E Formulations
DJ
09/23MORPHOSYS : Gets a Neutral rating from Goldman Sachs
MD
09/23AC IMMUNE : Semorinemab Didn't Meet Co-Primary Efficacy Endpoint in Early Alzheimer's Disease
DJ
09/23PFIZER : Gets FDA Priority Review of Xalkori in Rare Pediatric Lymphoma
DJ
09/23Johnson & Johnson Begins Final-Stage Testing of Covid-19 Vaccine
DJ
09/23NOVARTIS AG : Goldman Sachs reiterates its Buy rating
MD
09/23PHILIPS NV : Barclays remains its Buy rating
MD
Discover
09/23FRESENIUS SE : Buy rating from Goldman Sachs
MD
09/23FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Buy rating
MD
09/23GERRESHEIMER AG : Gets a Buy rating from Berenberg
MD
09/23FRESENIUS SE : Receives a Buy rating from Berenberg
MD
09/23CARL ZEISS MEDITEC AG : Gets a Neutral rating from Berenberg
MD
1  2  3  4  5  6  7  8  9  10Next